Phytopathogen transmitted from plant to human causing peritoneal dialysis-associated peritonitis

被引:2
作者
Jaroenpattrawut, Bunpring [1 ]
Poonvivatchaikarn, Ussanee [1 ]
Kanjanabuch, Talerngsak [2 ,3 ,4 ]
Eiam-Ong, Somchai [3 ]
机构
[1] Nakhon Pathom Hosp, Nephrol Clin, Nakhon Pathom, Thailand
[2] Chulalongkorn Univ, Fac Med, Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand
[3] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok 10330, Thailand
[4] King Chulalongkorn Mem Hosp, CAPD Excellent Ctr, Bangkok, Thailand
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2022年 / 42卷 / 02期
关键词
Epiphytotic disease; fungal peritonitis; peritonitis; phytopathogen; Sporothrix schenckii; sporotrichosis; DISEASES; UPDATE;
D O I
10.1177/08968608211048063
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report the first case of peritoneal dialysis (PD)-associated peritonitis due to Sporothrix schenckii, a thermally dimorphic black fungus transmitted from epiphytotic disease. The patient presented with PD-associated peritonitis and fungal colonisation inside the PD catheter's lumen after an exposing 'wet contamination' event with a phytopathogen 11 days prior to the onset of infection. The human pathogen and phytopathogen were confirmed the same species by nucleotide sequences of the internal transcribed spacer and large subunit regions of the ribosomal RNA gene. A 'wet contamination' should be closely monitored for an extended period, and a broader spectrum of organisms might lead to peritonitis, particularly in centres with a high prevalence of fungal infection. PD patients and their caregivers should have periodic retraining of aseptic technique and personnel hygiene. We also recommend a long course of antifungal medication in eradicating peritoneal sporotrichosis to prevent unfavourable outcomes and relapsing peritonitis from this organism.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 10 条
  • [1] Caring for Australians with Renal Impairment (CARI), 2004, Nephrology (Carlton), V9 Suppl 3, pS78
  • [2] Global epidemiology of sporotrichosis
    Chakrabarti, Arunaloke
    Bonifaz, Alexandro
    Gutierrez-Galhardo, Maria Clara
    Mochizuki, Takashi
    Li, Shanshan
    [J]. MEDICAL MYCOLOGY, 2015, 53 (01) : 3 - 14
  • [3] Sporothrix schenckii and Sporotrichosis
    de Lima Barros, Monica Bastos
    Paes, Rodrigo de Almeida
    Schubach, Armando Oliveira
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2011, 24 (04) : 633 - 654
  • [4] European Committee on Antimicrobial Susceptibility Testing (EUCAST) European Society of Clinical Microbiology and Diseases, CLIN BREAKP DOS ANT
  • [5] Fungal Dimorphism and Virulence: Molecular Mechanisms for Temperature Adaptation, Immune Evasion, and In Vivo Survival
    Gauthier, Gregory M.
    [J]. MEDIATORS OF INFLAMMATION, 2017, 2017
  • [6] Clinical practice guidelines for the management of sporotrichosis: 2007 update by the infectious diseases society of America
    Kauffman, Carol A.
    Bustamante, Beatriz
    Chapman, Stanley W.
    Pappas, Peter G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (10) : 1255 - 1265
  • [7] Kwon-Chung KJ., 1992, MED MYCOL, P707
  • [8] ISPD PERITONITIS RECOMMENDATIONS: 2016 UPDATE ON PREVENTION AND TREATMENT
    Li, Philip Kam-Tao
    Szeto, Cheuk Chun
    Piraino, Beth
    de Arteaga, Javier
    Fan, Stanley
    Figueiredo, Ana E.
    Fish, Douglas N.
    Goffin, Eric
    Kim, Yong-Lim
    Salzer, William
    Struijk, Dirk G.
    Teitelbaum, Isaac
    Johnson, David W.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2016, 36 (05): : 481 - 508
  • [9] Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
    Peng, LW
    Lien, YHH
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) : 162 - 166
  • [10] van der Riet FDJ, 2000, MED HYPOTHESES, V54, P310